Patient safety is not an afterthought; it is the foundation of every clinical trial.

On World Patient Safety Day 2025, we reaffirm our commitment to safeguarding every participant who takes part in our studies.

At Richmond Pharmacology, pharmacovigilance is central to this.

  • Every event is recorded and reviewed with care
  • Our safety team and Principal Investigators work tirelessly to ensure no safety signals are overlooked
  • Rigorous oversight protects today’s participants and tomorrow’s patients

Explore our new infographic to see how drug safety monitoring works in practice and why it matters.

Latest news

How Richmond Pharmacology Supports Sponsors Navigating ICH E6 (R3)

February 5, 2026
The updated ICH E6 (R3) guideline places greater emphasis on proportionality, risk-based oversight...
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event